by Pharmaguapa | Aug 18, 2021 | General, Social Media
I’m back, having taken time off this summer for a much needed holiday. I then followed this with some time offline. I did something that in the past I always said would be impossible – I took a holiday from social media. Yes – I did not check my...
by Pharmaguapa | Apr 6, 2021 | Content, General, marketing, Multichannel, Social Media
Next up on my content plan is a post to share what I am reading right now. I thought as part of this it would be helpful to share some of my favourite online resources around digital and social media marketing in the healthcare industry. If you are interested though...
by Pharmaguapa | Feb 26, 2021 | Autoimmune Disease, General, hashimoto's, Patient centric, Rare disease, Social Media
It’s Rare Disease Day this weekend! Every year the end of February sees this day focused on rare diseases. The aim of the disease day is to raise awareness amongst the general public and decision-makers about rare diseases and their impact on patients’...
by Pharmaguapa | Feb 18, 2021 | Autoimmune Disease, General, hashimoto's, Patient centric
Next up on my content plan is a post about inspirational quotations. At first I thought this would be easy – the internet is after all full of inspirational quotes. However I wanted to make it meaningful and tie it back to life as an autoimmune patient. ...
by Pharmaguapa | Jan 7, 2021 | Content, General, Multichannel, Social Media
I am not normally one for New Year’s resolutions. I find they are often intentions that are never fully realised as planned. The classic ones are often health related, for example drinking less or doing more exercise. We start the year with a great...
by Pharmaguapa | Dec 1, 2020 | Autoimmune Disease, General, hashimoto's, Leadership
As we near the end of this second lockdown I find myself reflecting on my lockdown experience. I have heard from quite a few friends that they have found this second lockdown even harder than the first. Many people I know have struggled with mental health and...
